Français Español Arabic
English

News Archive

01 July 2009

White Fly Trial Data Update

Following on from initial screening trials in 2008, Eden is pleased to announce the first results of its trial series conducted by Anadiag S.R.L looking at controlling whitefly (Trialeurodes vaporarium) in high value protected vegetable crops in Europe.

Eden's leading encapsulated terpene product gave control of the whitefly larvae and adults comparable to the market standard "Mycotal". Full scale registration trials are planned for later in 2009 to develop a product to control this global pest.

For trial data results please visit http://www.edenresearch.co.uk/html/products/trial-data/whitefly.asp

Tim Griffiths the Chief Executive of Eden Research plc said:-

"Whitefly causes millions of dollars of crop losses every year. As resistance development continues to grow to traditional synthetic pesticides, including abamectin, which is now coming off patent in many major markets, growers are increasingly adopting the use of biological control in the battle to control this pest.

The challenge for new products is to offer a level of control of the target pest without having damaging effects on the biological controls, so that growers can integrate their use to ensure maximum long term efficacy.

Eden's current lead compounds have demonstrated both high efficacy against whitefly but also negligible impact upon beneficial species."

 

For further information:

Tim Griffiths, Chief Executive
Eden Research plc
Tel: 01993 868844

 

ABOUT EDEN RESEARCH PLC

Eden Research plc is a UK publicly listed company on the PLUS Market, specialising in the development of agrochemical products and intellectual property through licensing and marketing agreements.

Eden is focused on developing products for the agricultural sector through the application of terpene chemistry and other patented environmentally friendly technologies. Eden is currently working alongside universities and partner companies in developing its product portfolio towards commercialisation.

For further information please visit www.edenresearch.com.

 

Back to Latest News